SEC Tracker
Get the app
ARAY · XBRL financial data

Accuray financial statements, every quarter

The same tables from 14 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ARAY's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers103,892107,238101,132134,289*101,545116,174113,243127,543*93,942102,241104,845100,919*
Cost of revenue64,39971,33672,05895,837*67,07674,28281,61688,564*67,39478,16979,55165,842*
Gross profit39,49335,90229,07438,452*34,46941,89231,62738,979*26,54824,07225,29435,077*
Research and development14,01315,28110,9099,529*12,11613,64410,71211,470*11,36910,6508,1787,707*
General and administrative13,02313,22412,40911,410*12,82012,42710,75811,866*14,51910,06511,22511,512*
Total operating expenses37,28039,86633,63631,635*36,61837,18530,58034,745*37,86135,63834,38129,553*
Operating income (loss)2,213(3,964)(4,562)6,817*(2,149)4,7071,0474,234*(11,313)(11,566)(9,087)5,524*
Interest income———year only303278322289*272246181120*
Interest expense2,9222,9222,8842,896*2,9552,8832,8904,226*8,0527,7098,4468,698*
Other income (expense)(3,681)(4,352)(2,360)7,855*1,847(196)(1,294)202*(407)(106)2,4293,095*
Income tax expense (benefit)1,932878444471*625695457948*471573468434*
Net income (loss)(2,969)(9,621)(6,342)3,387*(3,954)2,537(1,297)1,123*(21,678)(13,770)(11,805)(1,941)*
Earnings per share, basic USD per share(0.03)(0.10)(0.06)0.03*(0.04)0.03(0.01)0.01*(0.18)(0.11)(0.09)—
Earnings per share, diluted USD per share(0.03)(0.10)(0.06)0.03*(0.04)0.02(0.01)—(0.18)(0.11)——
Weighted average shares, basic thousands of shares96,55597,77699,19799,584*100,225101,405102,825106,661*119121124—
Weighted average shares, diluted thousands of shares96,55597,77699,19799,584*100,225103,746102,825104,294*118,946121——

Balance sheet

CSV

Fiscal quarters (ARAY's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents76,91872,75660,45068,57059,20962,58477,82457,41663,34441,29538,06740,623
Accounts receivable———92,001———83,19254,37860,96264,57367,409
Inventory149,977155,228159,566138,324154,883148,826146,445141,020155,503150,962156,626147,075
Prepaid and other current assets28,79825,02019,04323,00621,45625,44029,20333,50129,37336,96833,46331,783
Total current assets334,147331,170313,910323,236329,543325,891333,458317,465303,603292,388293,216287,777
Property and equipment, net24,96325,91925,38724,77425,34226,88127,08128,65829,01329,25629,00227,316
Right-of-use asset24,37823,09429,12733,77333,13631,71634,02333,11532,09930,80728,89827,512
Goodwill57,65657,77157,68257,67257,81057,64357,72057,80257,82057,84957,88257,911
Total assets476,830476,350462,527468,627473,078478,382484,291470,239456,816448,009447,602443,676
Accounts payable34,87739,18044,43050,02049,80853,99146,31934,03342,40043,51952,80540,554
Current portion of long-term debt6,2296,7387,2487,7567,7697,5607,57412,73412,85311,11011,1601,500
Total current liabilities201,449209,306198,390195,267201,806201,453203,429192,579194,612199,439205,844191,405
Long-term debt169,792168,020166,246164,400162,471167,953166,209123,786127,316124,777134,020146,370
Lease liability, non-current22,80621,75828,21732,37331,77330,45933,35232,48231,48130,18428,98927,768
Total liabilities425,886428,697421,446423,543427,855430,491434,708389,070394,949394,589405,895401,977
Accumulated deficit(505,105)(514,726)(521,068)(517,681)(521,635)(519,098)(520,395)(519,272)(540,950)(554,720)(566,525)(568,466)
Total stockholders' equity50,94447,65341,08145,08445,22347,89149,58381,16961,86753,42041,70741,699
Total liabilities and equity476,830476,350462,527468,627473,078478,382484,291470,239456,816448,009447,602443,676
Common shares outstanding (cover page) thousands of shares97,07299,16999,244100,268100,565102,831103,013112,677113,341118,783118,964119,439

Cash flows

CSV

Fiscal quarters (ARAY's year ends in late June)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(2,969)(9,621)(6,342)3,387*(3,954)2,537(1,297)1,123*(21,678)(13,770)(11,805)(1,941)*
Stock-based compensation2,3922,314*2,735*2,043*2,3532,284*2,745*2,819*2,515882*1,378*1,680*
Depreciation and amortization1,2511,546*1,601*1,507*1,4641,513*1,575*1,598*1,6762,163*2,078*2,025*
Net cash from operating activities(8,591)(5,093)*(8,102)*9,882*(7,294)1,801*18,061*(9,708)*12,180(15,986)*(5,602)*2,427*
Purchases of property and equipment1,0921,249*795*465*1,120874*958*1,320*1,9043,025*471*461*
Net cash from investing activities(1,092)(1,249)*(795)*(465)*(1,120)(1,570)*(2,431)*(3,402)*(3,824)(5,596)*(1,506)*(1,353)*
Proceeds from issuing common stock——0*887*——0*771*——0*149*
Net cash from financing activities(1,500)(257)*(1,500)*(694)*(2,173)5,766*(2,000)*(5,845)*(475)(282)*4,110*3,624*
Net change in cash(12,511)(4,199)*(12,338)*8,238*(9,260)4,256*14,856*(18,110)*7,794(22,059)*(3,426)*4,324*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Accuray40,623100,919*2,427*119.4M— 10-KJun 30, 2026
Lucid Diagnostics33,404not reported(11,297)*203.2M3.0 quarters 10-QJun 30, 2026
Fonar53,65026,4721,580*not reported— 10-QMar 31, 2026
Apyx Medical27,61713,884(3,490)*42.1M7.9 quarters 10-QJun 30, 2026
Microbot Medical3,152241(4,989)*67.2M13.5 quarters 10-QJun 30, 2026
TELA Bio30,42419,291(9,381)*44.9M3.2 quarters 10-QJun 30, 2026
enVVeno Medical2,585not reported(3,178)*694,8265.6 quarters 10-QSep 30, 2026
Pulmonx52,69022,835(3,183)*43.6M8.5 quarters 10-QSep 30, 2026
Spectral AI14,0003,524(4,097)*32.2M3.4 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.